Journal Homepage Image

World Journal of Personalized Medicine

Editor-in-Chief

Ivan I. Dedov, MD, PhD, Professor
the vice-president of the Russian academy of Sciences, main specialist of the Ministry of health of Russian Federation in endocrinology, president of the Russian association of endocrinologists, director of Endocrinology research centre (Moscow)

Publication model

Medical Open Access electronic-only journal

Peer-review type: open post-publication peer-review process (see details).

Publication scedule: articles are published as soon as they are ready.

Aims and research fields of the journal

The peer-reviewed medical journal “World Journal of Personalized Medicine” aims to publish the highest quality articles in the field of personalized medicine.

The journal publish review papers, original articles, case reports, and letters to the editor.

The journal provides a forum for exchange of ideas between basic and clinical scientists as well as medical professionals, healthcare organizations, and patients who seek the best strategies for integrating personalized medicine into clinical practice.

The journal covers all aspects of personalized medicine. Key areas include:

  • Basic and Clinical Immunology
  • Bioinformatics
  • Biomarker studies
  • Cell, Molecular, and Stem Cell biology
  • Cytogenetics, Genomics, Proteomics, and Metabolomics
  • Drug discovery and delivery
  • Molecular Endocrinology
  • Epigenetics
  • Ethical, legal, and social issues in personalized medicine
  • Molecular diagnostics
  • Neuroscience
  • Nutrigenomics
  • Oncology
  • Orthomolecular medicine
  • Pathology
  • Pharmacogenomic
  • Preemptive medicine (Personalized prevention)
  • Regenerative medicine
  • System biology

Current Issue

Vol 1, No 1 (2017)

Review
Stages of development and implementation of personalized medicine technologies in clinical practice
Sychev D.A.
World Journal of Personalized Medicine. 2017;1(1):1-4
views303
PDF
(Rus)
Pharmacodynamic gene polymorphism and adverse drug reactionsthen applying antipsychotic drugs
Zastrozhin M.S., Sychev D.A., Grishina E.A., Savchenko L.M., Bryun E.A.
World Journal of Personalized Medicine. 2017;1(1):5-12
views165
PDF
(Rus)
The prospect of pluripotent stem cells for diabetes mellitus treatment
Panova A.V., Goliudsova D.V., Kiselev S.L.
World Journal of Personalized Medicine. 2017;1(1):13-17
views329
PDF
(Rus)
Original Studies
Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms
Ivashchenko D.V., Ryzhykova K.A., Sozaeva Z.A., Zastrozhin M.S., Grishina E.A., Savchenko L.M., Bryun E.A., Sychev D.A.
World Journal of Personalized Medicine. 2017;1(1):18-26
views162
PDF
(Rus)
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Savelyeva M.I., Panchenko J.S., Urvantseva I.A., Ignatova A.K., Poddubnaya I.V.
World Journal of Personalized Medicine. 2017;1(1):27-35
views324
PDF
(Rus)
The personalized approach to neonatal diabetes therapy depending on the genetic defect
Tikhonovich Y.V., Zubkova N.A., Tiulpakov A.N.
World Journal of Personalized Medicine. 2017;1(1):36-39
views299
PDF
(Rus)
Case report
Genotype-based personalized correction of glycemic control in patients with MODY due to mutations in GCK, HNF1A AND HNF4A genes
Zubkova N.A., Gioeva O.A., Tikhonovich Y.V., Petrov V.M., Vasiliev E.V., Tyulpakov A.N., Dedov I.I.
World Journal of Personalized Medicine. 2017;1(1):40-48
views265
PDF
(Rus)